Related references
Note: Only part of the references are listed.Selective proton-observed, carbon-edited (selPOCE) MRS method for measurement of glutamate and glutamine 13C-labeling in the human frontal cortex
Henk M. De Feyter et al.
MAGNETIC RESONANCE IN MEDICINE (2018)
Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression
I. Esterlis et al.
MOLECULAR PSYCHIATRY (2018)
Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder
Dustin Scheinost et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Common Neurotransmission Recruited in (R,S)-Ketamine and (2R, 6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects
Thu Ha Pham et al.
BIOLOGICAL PSYCHIATRY (2018)
Intracellular Signaling Pathways Involved in (S)- and (R)-Ketamine Antidepressant Actions
Panos Zanos et al.
BIOLOGICAL PSYCHIATRY (2018)
Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine
Sriparna Ghosal et al.
BIOLOGICAL PSYCHIATRY (2018)
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders A Randomized Clinical Trial
Daniel C. Javitt et al.
JAMA PSYCHIATRY (2018)
Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
G. M. I. Chowdhury et al.
MOLECULAR PSYCHIATRY (2017)
Ketamine Treatment and Global Brain Connectivity in Major Depression
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Comparison of direct 13C and indirect 1H-[13C] MR detection methods for the study of dynamic metabolic turnover in the human brain
Hao Chen et al.
JOURNAL OF MAGNETIC RESONANCE (2017)
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
ACNP 56th Annual Meeting: Poster Session I, December 4, 2017
NEUROPSYCHOPHARMACOLOGY (2017)
Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment
Chadi G. Abdallah et al.
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2017)
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
M. S. Milak et al.
MOLECULAR PSYCHIATRY (2016)
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
Chadi G. Abdallah et al.
DEPRESSION AND ANXIETY (2016)
Reduced Global Functional Connectivity of the Medial Prefrontal Cortex in Major Depressive Disorder
James W. Murrough et al.
HUMAN BRAIN MAPPING (2016)
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine
Eric S. Wohleb et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia
Alan Anticevic et al.
BIOLOGICAL PSYCHIATRY (2015)
In Vivo Ketamine-Induced Changes in [11C] ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5
Christine DeLorenzo et al.
BIOLOGICAL PSYCHIATRY (2015)
Glutamate Metabolism in Major Depressive Disorder
Chadi G. Abdallah et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
Bhavya Voleti et al.
BIOLOGICAL PSYCHIATRY (2013)
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
N. R. Driesen et al.
MOLECULAR PSYCHIATRY (2013)
The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity
Naomi R. Driesen et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels
Fahmeed Hyder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Glutamatergic Modulation of Auditory Information Processing in the Human Brain
Handan Gunduz-Bruce et al.
BIOLOGICAL PSYCHIATRY (2012)
1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism
Golam M. I. Chowdhury et al.
BIOLOGICAL PSYCHIATRY (2012)
Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study
Matthew J. Taylor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence
Deepak Cyril D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia
Alan Anticevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Capturing the Angel in Angel Dust: Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
Bita Moghaddam et al.
SCHIZOPHRENIA BULLETIN (2012)
State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide
Robin A. de Graaf et al.
NMR IN BIOMEDICINE (2011)
13C MRS studies of neuroenergetics and neurotransmitter cycling in humans
Douglas L. Rothman et al.
NMR IN BIOMEDICINE (2011)
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
John H. Krystal et al.
CNS DRUGS (2010)
13C MRS of occipital and frontal lobes at 3 T using a volume coil for stochastic proton decoupling
Shizhe Li et al.
NMR IN BIOMEDICINE (2010)
In Vivo 13C Magnetic Resonance Spectroscopy of Human Brain on a Clinical 3 T Scanner Using [2-13C]Glucose Infusion and Low-Power Stochastic Decoupling
Shizhe Li et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Glutamate and the neural basis of the subjective effects of ketamine
J. F. William Deakin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe
Napapon Sailasuta et al.
JOURNAL OF MAGNETIC RESONANCE (2008)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
JH Krystal et al.
PSYCHOPHARMACOLOGY (2005)
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study
LM Rowland et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Energetic basis of brain activity: implications for neuroimaging
RG Shulman et al.
TRENDS IN NEUROSCIENCES (2004)
Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients
JH Krystal et al.
NEUROPSYCHOPHARMACOLOGY (2003)
A mathematical model of compartmentalized neurotransmitter metabolism in the human brain
R Gruetter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
